Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Seminars in Thoracic and Cardiovascular Surgery
|
March 31, 2007
Cost considerations with tight glycemic control in the acute care setting
Daniel E Hilleman
Journal of Managed Care Pharmacy : JMCP
|
July 7, 2005
New treatment options in COPD
Daniel E Hilleman
Cardiovascular Therapeutics
|
July 31, 2016
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin
Kathleen A Packard, Daniel E Hilleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
April 9, 2026
Lp(a): A potentially modifiable cardiovascular risk factor
Daniel E Hilleman, James M Backes
Future Cardiology
|
March 1, 2021
New and emerging lipid-lowering therapy
James M Backes, Daniel E Hilleman
Pharmacotherapy
|
November 5, 2003
Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future
Michele A Faulkner, Daniel E Hilleman
Pharmacotherapy
|
January 17, 2002
Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials
Daniel E Hilleman, Sarah A Spinler
Journal of Vascular and Interventional Radiology : JVIR
|
February 26, 2008
Clinical and economic evaluation of the Trellis-8 infusion catheter for deep vein thrombosis
Daniel E Hilleman, Mahmood K Razavi
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
September 19, 2024
A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary Supplements
James M Backes, Daniel E Hilleman
Managed Care (Langhorne, Pa.)
|
August 3, 2010
Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy
Mark A Malesker, Daniel E Hilleman
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Seminars in Thoracic and Cardiovascular Surgery
|
March 31, 2007
Cost considerations with tight glycemic control in the acute care setting
Daniel E Hilleman
Journal of Managed Care Pharmacy : JMCP
|
July 7, 2005
New treatment options in COPD
Daniel E Hilleman
Cardiovascular Therapeutics
|
July 31, 2016
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin
Kathleen A Packard, Daniel E Hilleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
April 9, 2026
Lp(a): A potentially modifiable cardiovascular risk factor
Daniel E Hilleman, James M Backes
Future Cardiology
|
March 1, 2021
New and emerging lipid-lowering therapy
James M Backes, Daniel E Hilleman
Pharmacotherapy
|
November 5, 2003
Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future
Michele A Faulkner, Daniel E Hilleman
Pharmacotherapy
|
January 17, 2002
Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials
Daniel E Hilleman, Sarah A Spinler
Journal of Vascular and Interventional Radiology : JVIR
|
February 26, 2008
Clinical and economic evaluation of the Trellis-8 infusion catheter for deep vein thrombosis
Daniel E Hilleman, Mahmood K Razavi
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
September 19, 2024
A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary Supplements
James M Backes, Daniel E Hilleman
Managed Care (Langhorne, Pa.)
|
August 3, 2010
Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy
Mark A Malesker, Daniel E Hilleman
Page
of 7